Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Activase injection?

See the DrugPatentWatch profile for Activase

What is Activase injection used for?

Activase is a brand of alteplase, a thrombolytic (“clot-busting”) medicine given by injection. It’s used to dissolve blood clots in certain acute, time-sensitive conditions, including ischemic stroke and some types of heart-related artery blockage (acute myocardial infarction).

What is Activase (alteplase), and how does the injection work?

Activase injection contains alteplase, a tissue plasminogen activator (tPA). It works by activating plasminogen to form plasmin, which breaks down fibrin in blood clots, helping restore blood flow.

How is Activase injection given?

Activase is administered as an injection (typically through a vein/IV in acute care settings). Dosing and whether it’s given as a bolus plus infusion depend on the condition being treated and the patient’s factors, so administration is done under clinician protocols.

How long does treatment have to start after symptom onset?

Because Activase is used for emergency clot-related events, timing matters. The medicine is used in acute settings with established time windows and eligibility criteria for each indication.

What side effects do patients ask about?

The main risk associated with thrombolytics like Activase is bleeding. Patients and clinicians watch closely for signs of serious hemorrhage during and after treatment. Other possible side effects can include reactions related to IV administration, and the overall safety depends on patient-specific bleeding risk.

Who should not receive Activase (major contraindications)?

Activase is generally avoided when bleeding risk is high or when a patient has certain conditions that make thrombolysis unsafe. Examples commonly include recent serious bleeding, certain recent surgeries or procedures, and other factors related to stroke/bleeding risk. Eligibility depends on the specific scenario and clinical history.

Are there alternative thrombolytics or stroke treatments?

For clot-related emergencies, alternatives may include other thrombolytic agents (depending on the condition), plus non-thrombolytic approaches such as mechanical procedures in some stroke and heart scenarios. Which option is used depends on timing, imaging results, and risk/eligibility.

Where can I find patent and company information for Activase/alteplase?

If you’re researching commercial or patent history for Activase (alteplase), DrugPatentWatch.com tracks drug patent and exclusivity information and can help identify relevant rights and changes over time.

Sources:
- 1



Other Questions About Activase :

Activase price? Activase documentation? Activase cost? Activase price? Activase price?